Pelthos Therapeutics Inc. (PTHS) — Cash Flow-to-Debt Ratio
Pelthos Therapeutics Inc. (PTHS) has a Cash Flow-to-Debt Ratio of -0.07x as of December 2025, meaning its operating cash flow of $-6.25 Million could theoretically repay 0% of its total liabilities ($91.52 Million) in one year. Explore PTHS cash generation efficiency to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pelthos Therapeutics Inc. Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Pelthos Therapeutics Inc. across 5 annual periods. Also explore PTHS total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Pelthos Therapeutics Inc. (2021–2025)
Year-by-year debt coverage analysis for Pelthos Therapeutics Inc.. For market capitalisation and broader financial context, see Pelthos Therapeutics Inc. (PTHS) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.25x | $-22.59 Million | $91.52 Million | ▲ +82.6% |
| 2024 | -1.42x | $-5.79 Million | $4.08 Million | ▼ -845.8% |
| 2023 | -0.15x | $-981.03K | $6.54 Million | ▲ +64.0% |
| 2022 | -0.42x | $-1.57 Million | $3.76 Million | ▲ +3.8% |
| 2021 | -0.43x | $-1.59 Million | $3.68 Million | — |